Bioaccessibility of lead and arsenic in traditional Indian medicines

被引:37
作者
Koch, Iris [1 ]
Moriarty, Maeve [1 ]
House, Kim [1 ]
Sui, Jie [1 ]
Cullen, William R. [2 ]
Saper, Robert B. [3 ]
Reimer, Kenneth J. [1 ]
机构
[1] Royal Mil Coll Canada, Dept Chem & Chem Engn, Environm Sci Grp, Kingston, ON K7K 7B4, Canada
[2] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada
[3] Boston Univ, Sch Med, Dept Family Med, Boston, MA 02118 USA
基金
美国国家卫生研究院; 加拿大自然科学与工程研究理事会;
关键词
Arsenic; Lead; Bioaccessibility; Ayurvedic; Speciation; Risk; EXTRACTION; REDUCTION; TOXICITY; KINETICS; METALS; PLANTS;
D O I
10.1016/j.scitotenv.2011.07.059
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Arsenic and lead have been found in a number of traditional Ayurvedic medicines, and the practice of Rasa Shastra (combining herbs with metals, minerals and gems), or plant ingredients that contain these elements, may be possible sources. To obtain an estimate of arsenic and lead solubility in the human gastrointestinal tract, bioaccessibility of the two elements was measured in 42 medicines, using a physiologically-based extraction test. The test consisted of a gastric phase at pH 1.8 containing organic acids, pepsin and salt, followed by an intestinal phase, at pH 7 and containing bile and pancreatin. Arsenic speciation was measured in a subset of samples that had sufficiently high arsenic concentrations for the X-ray absorption near edge structure analysis used. Bioaccessible lead was found in 76% of samples, with a large range of bioaccessibility results, but only 29% of samples had bioaccessible arsenic. Lead bioaccessibility was high (close to 100%) in a medicine (Mahayograj Guggulu) that had been compounded with bhasmas (calcined minerals), including naga (lead) bhasma. For the samples in which arsenic speciation was measured, bioaccessible arsenic was correlated with the sum of As(V)-O and As(III)-O and negatively correlated with As-S. These results suggest that the bioaccessible species in the samples had been oxidized from assumed As-S raw medicinal ingredients (realgar, As4S4, added to naga (lead) bhasma and As(III)-S species in plants). Consumption at recommended doses of all medicines with bioaccessibile lead or arsenic would lead to the exceedance of at least one standard for acceptable daily intake of toxic elements. Crown Copyright (C) 2011 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:4545 / 4552
页数:8
相关论文
共 47 条
  • [1] Examination of arsenic(III) and (V) uptake by the desert plant species mesquite (Prosopis spp.) using X-ray absorption spectroscopy
    Aldrich, M. V.
    Peralta-Videa, J. R.
    Parsons, J. G.
    Gardea-Torresdey, J. L.
    [J]. SCIENCE OF THE TOTAL ENVIRONMENT, 2007, 379 (2-3) : 249 - 255
  • [2] Bioaccessibility of essential and non-essential metals in commercial shellfish from Western Europe and Asia
    Amiard, Jean-Claude
    Amiard-Triquet, Claude
    Charbonnier, Laetitia
    Mesnil, Aurelie
    Rainbow, Philip S.
    Wang, Wen-Xiong
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 2008, 46 (06) : 2010 - 2022
  • [3] Insect excretes unusual six-coordinate pentavalent arsenic species
    Andrahennadi, Ruwandi
    Fu, Juxia
    Pushie, M. Jake
    Wiramanaden, Cheryl I. E.
    George, Graham N.
    Pickering, Ingrid J.
    [J]. ENVIRONMENTAL CHEMISTRY, 2009, 6 (04) : 298 - 304
  • [4] [Anonymous], 2007, Method 6200: Field portable X-ray fluorescence spectrometry for the determination of elemental concentrations in soils and sediments
  • [5] The effect of dosing vehicle on arsenic bioaccessibility in smelter-contaminated soils
    Basta, Nicholas T.
    Foster, Jill N.
    Dayton, E. A.
    Rodriguez, Robin R.
    Casteel, Stan W.
    [J]. JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART A-TOXIC/HAZARDOUS SUBSTANCES & ENVIRONMENTAL ENGINEERING, 2007, 42 (09): : 1275 - 1281
  • [6] Stability of arsenic peptides in plant extracts: off-line versus on-line parallel elemental and molecular mass spectrometric detection for liquid chromatographic separation
    Bluemlein, Katharina
    Raab, Andrea
    Feldmann, Jorg
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2009, 393 (01) : 357 - 366
  • [7] Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P582
  • [8] Controlled-release drug delivery systems for prolonged gastric residence: An overview
    Deshpande, AA
    Rhodes, CT
    Shah, NH
    Malick, AW
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (06) : 531 - 539
  • [9] Heavy metals in traditional Indian remedies
    Ernst, E
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 57 (12) : 891 - 896
  • [10] Franke FW, 1936, J PHARMACOL EXP THER, V58, P454